ישראל -
עברית -
Ministry of Health
קומדין 3 מג
taro pharmaceutical industries ltd - warfarin sodium - טבליה - warfarin sodium 3 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.
ישראל -
עברית -
Ministry of Health
קומדין 4 מג
taro pharmaceutical industries ltd - warfarin sodium - טבליה - warfarin sodium 4 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.
ישראל -
עברית -
Ministry of Health
קומדין 6 מג
taro pharmaceutical industries ltd - warfarin sodium - טבליה - warfarin sodium 6 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonar embolis. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.
ישראל -
עברית -
Ministry of Health
קומדין 7.5 מג
taro pharmaceutical industries ltd - warfarin sodium - טבליה - warfarin sodium 7.5 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.
ישראל -
עברית -
Ministry of Health
קומדין 10 מג
taro pharmaceutical industries ltd - warfarin sodium - טבליה - warfarin sodium 10 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.
ישראל -
עברית -
Ministry of Health
"ecg electrodes,electrosurgical pencils and electrosurgical grounding pads"
"י.גיל מדיקל בע""מ" - צוות טכני - לצורך בדיקת א.ק.ג לחולה
ישראל -
עברית -
Ministry of Health
eelctrosurgical pencils+esu grounding pl
י.גיל מדיקל בע"מ - רופא - עפרונות ופלטות לדיאטרמיה
ישראל -
עברית -
Ministry of Health
electrosurgery, grounding plates, pencils blades, ecg acc., oxtgen masks, leads for transoesophageal monotoring.
ג.ש גל בע"מ - רופא - חיתוכים של רקמות בחדר ניתוח
ישראל -
עברית -
Ministry of Health
קטמין פרופארם 10 מגמל
propharm ltd - ketamine as hydrochloride - תמיסה להזרקה\אינפוזיה - ketamine as hydrochloride 10 mg/ml - ketamine
ישראל -
עברית -
Ministry of Health
קומדין 1 מג
taro pharmaceutical industries ltd - warfarin sodium - טבליה - warfarin sodium 1 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.